Natural killer cells could form the next generation of cancer immunotherapies, but in order to fulfill this promise, they’ll need to overcome some of the challenges of the first generation of cell ...

Ginkgo Bioworks’ swift moving business development team is slowing down long enough to load up some new chimeric antigen receptor (CAR) assets from Modulus Therapeutics. The deal will see Ginkgo pick ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Nvidia today launched Modulus, a framework for developing ...

Toray Industries Inc. (Tokyo, Japan) has developed Torayca M46X carbon fiber, a material offering that is reported to be around 20% stronger than others in the Torayca MX series while maintaining a ...

Modulus Therapeutics recently emerged from stealth with technology from various disciplines and seed funding that the startup is using to develop better cell therapies. Natural killer cells directed ...